Euroinvestment (WAR:VIV) ROE % Adjusted to Book Value: 0.00% (As of Sep. 2024)


What is Euroinvestment ROE % Adjusted to Book Value?

Euroinvestment WAR:VIV +52.27% ROE % Adjusted to Book Value is 0.00% as of Sep. 2024.

Euroinvestment's ROE % for the quarter that ended in Sep. 2024 was 0.00%. Euroinvestment's PB Ratio for the quarter that ended in Sep. 2024 was N/A. Euroinvestment's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was N/A.

Euroinvestment ROE % Adjusted to Book Value Related Terms

Euroinvestment ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Euroinvestment's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroinvestment ROE % Adjusted to Book Value Chart

Euroinvestment Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec18 Dec19 Dec20 Dec21
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 Negative Equity 0.00 0.00

Euroinvestment Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

WAR:VIV vs TMO, DHR, IQV: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Euroinvestment's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Euroinvestment ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Euroinvestment's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Euroinvestment's ROE % Adjusted to Book Value falls into.


Euroinvestment ROE % Adjusted to Book Value Calculation

Euroinvestment's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2021 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Euroinvestment's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Euroinvestment (WAR:VIV) has a ROE % Adjusted to Book Value of 0.00% as of Sep. 2024. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Euroinvestment and its competitors.
Is Euroinvestment's ROE % Adjusted to Book Value too high?
Euroinvestment's current ROE % Adjusted to Book Value is 0.00%.
How does Euroinvestment's ROE % Adjusted to Book Value compare to TMO and DHR?
Euroinvestment's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Euroinvestment and its competitors. Euroinvestment's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroinvestment stock overvalued right now?
Euroinvestment (WAR:VIV) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Euroinvestment (WAR:VIV), the current ROE % Adjusted to Book Value is 0.00% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Euroinvestment Business Description

Address ul. Krucza 16/22, Warsaw, POL, 00-526
Euroinvestment SA is a holding company. It is engaged in providing dental and prosthetic laboratory services. It serves through a network of 6 clinics in Warsaw, Poland.